Aims-A study was conducted to determine the capability of the recently developed National Eye Institute (NEI) Scheimpflug cataract imaging system in detecting changes in the nuclear region of the lens over a 1 year period. Methods-Twenty five eyes with pure nuclear cataracts with mean nuclear densities <0 30 optical density units (ODU) (Oxford,7 Wilmer,20 Wisconsin21).
months later. Computerised densitometry using the NEI Scheimpflug cataract imaging system was performed. Clinical grading of the lenses was also done using the Lens Opacities Classification System II (LOCS II). For densitometry, a change of plus or minus 0-023 ODU (the 99% range) in mean density in the nuclear area was considered a progression or regression at 1 year. Results-Using the Scheimpflug densitometry, 14 of the 25 cataractous eyes showed significant progression at 1 year. In the normal control group, only three of the 30 eyes showed significant progression. In contrast, using the LOCS II clinical grading, only two of the 25 cataractous eyes showed a one step increase, two ofthe 30 controls progressed at 1 year, and none regressed. There was no significant difference in visual acuity. Conclusion-This study suggests the value of the NEI Scheimpflug cataract imaging system in detecting nuclear change within 1 year. However, clinically significant changes may require longer follow up periods. These data will be useful in planning future longitudinal studies of nuclear cataracts, such as for clinical trials of anticataract drugs. (Bry Ophthalmol 1995; 79: [527] [528] [529] [530] [531] [532] [533] [534] Various cataract classification and grading systems have been proposed in the past 30 years to study cataract progression, but few of these have been used for longitudinal studies of cataract. 122 The nuclear region of the lens, in general, is studied using a sagittal section of the lens with a slit-lamp narrow beam. Reproducibility tests have been described on the various techniques such as Scheimpflug (Topcon, Oxford, and Nidek systems)5-'7 and slit-lamp photography,18 20 Figure 2 summarises the results. The nuclear density at baseline for each eye was plotted against the nuclear density at the 12 month follow up visit. Note in this figure that the normal controls (meaning clear lenses with corresponding LOCS II clinical grade of 0) are distributed mainly around the lower density values, whereas the nuclear cataract group were distributed mainly in the higher densities. The area within the diagonal lines represents the 99% range obtained from the reproducibility study'7 which contains all points for which the difference between the measurements at baseline and the 12 month visit is within 0O023 ODU. Therefore, points above or below these lines can be considered progression or regression, respectively.
As shown in Figure 2 and density, denoting that they progressed at 1 year, and 11 did not show a significant change. None of the 25 regressed. In the normal control group, three of the 30 showed significant increases in density and the rest did not show significant change (Fig 2, Table 1 ).
With the LOCS II clinical grading, four of 25 cataract cases progressed by one step in nuclear opalescence at 1 year, of which only two were confirmed by a third later visit. Two cataract cases showed a regression at 1 year, but were not confirmed by the third visit. These may represent the variability in the system. Three of the normal controls changed in opalescence at 1 year, two of which were confirmed at the third visit. Table 3 shows the data for those eyes which changed showing the results of the third confirmatory visit.
Of the 14 cataractous eyes that progressed by Scheimpflug densitometry, two lost 2 lines (5 letters= 1 line). Of the 11 cataractous eyes which did not progress by Scheimpflug densitometry, one lost 2 lines. Of the three normals that progressed, none lost 2 or more lines of visual acuity and of the 27 normals that did not progress, none lost 2 or more lines of visual acuity. Therefore, three cataractous eyes had clinically significant visual acuity loss (2 lines) compared with none in the control group.
Figures 3A-F, are examples of images from three subjects obtained with the Zeiss slit-lamp according to the protocol described by Chylack et al,18 at baseline and at 12 months. Figure   4A -F are corresponding images from the three subjects obtained with the Scheimpflug Figure 3 Among the reasons for this sensitivity may be that the Scheimpflug densitometry uses a continuous scale (in optical density units), and that computerised objective systems like the Scheimpflug system are programmed to pick up smaller density changes which the human eye cannot differentiate. In addition, automated systems like the Scheimpflug system may be more consistent and reliable over time when compared with subjective systems like the LOCS II, and visual acuity testing, which may be prone to problems such as examiner and patient drift, tiredness, Daties, Magno, Freidlin We have previously reported on the studies to convert and express the mean nuclear densities obtained from Scheimpflug photography into optical density units for standardisation, and on the development of a computerised image analysis system (the NEI Scheimpflug cataract imaging system) which separates and delineates the nuclear region apart from the anterior and posterior cortical regions. Conversion of pixel values to optical density units was accomplished by taking images of a series of calibrated neutral density filters (0 09 to 1-33 ODU) with the existing hardware provided by Zeiss using 13 different illumination levels (from 8 to 14V). The resulting calibration tables then allowed correlation of pixel intensities to optical densities units. '6 17 The details of the software development are described in a previous paper. '6 Because of the new system's speed, the operator can capture, store, and analyse a cataract image in a few seconds, as well as compare the image analysis with previous image analyses from the same eye. The system, therefore, provides appropriate integrity for the data as well as formats for documenting and monitoring lens opacities. The developments in software were coupled with developments in hardware. We now use a Macintosh Quadra 700 computer and the optical disk storage system.
During the actual usage of the system, it was noted that the upgraded Scheimpflug system had other advantages. With the new Scheimpflug system, the examiner can visualise the image about to be stored and check it for appropriate exposure (using a specially developed exposure check software system) to make sure that the image is within the dynamic range of the camera to allow for future progression, and that the entire lens image is aligned and centred. A poor image can be quickly discarded and the appropriate one obtained. A minor advantage for the patient's viewpoint is that the patient can see his or her cataract at each visit as presented on the computer monitor, and makes their own assessment about the state of their cataract. For many patients, this was very educational and helped them grasp the extent of their eye problem.
The obvious disadvantage of this system is its cost as well as the availability of duplicate equipment for multicentre trials. This may limit its applicability in large scale studies which are usually multicentre. One possible solution to this is the standardisation of a video camera adapted to mount on a slit-lamp and obtain a slit image of the lens which can then be stored and sent to a centre. This system can then perform the analysis using the system we developed. The recently introduced Zeiss video system which can be mounted on any lack of attention, and/or bias. Lastly, the optical disk storage and digital format used in the Scheimpflug system is an important factor contributing to its reproducibility, and has the advantage of dependable, stable, and easily accessible data.
Zeiss slit-lamp is a suitable candidate in this strategy. In theory, the NEI Scheimpflug cataract imaging system may be adopted and modified to analyse any slit image of the lens obtained with other cameras according to certain specifications. This is presently being explored. They found the Scheimpflug component of the system useful in detecting no untoward effects of the drug in the nuclear portion of the lens within a year, the same period we used in this study. They noted that the 'nuclear dip measure', an index they derived to represent nuclear cataract had 70% power to detect a change in either direction at a significance level of 0 05 for doubling of the effect.
Although we need to be cautious because of our small numbers in this study, the Scheimpflug imaging method may help identify erstwhile normal patients who may have a higher risk of developing nuclear cataracts. The three normal controls that progressed at 1 year are over 55 years old, and would be more prone to develop cataracts than younger people. This finding could be important in that these three patients may be the ones who will develop definite nuclear cataracts in the near future and would be a good target for anticataract drug treatment. Hence, we plan to pursue this in future studies. One obstacle we encountered was the difficulty of finding normal controls over age 55, since many volunteers were found to have some early lens opacities and therefore were disqualified.
In summary, we found the NEI Scheimpflug cataract imaging system to be useful, sensitive, reproducible, and efficient for monitoring change in the nuclear region of normal and cataractous lenses. However, a longer follow up period will be required to correlate the changes detected by this device to clinically significant change in visual acuity.
